Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality8/10

UHT Q2 2026 results show higher FFO, land sale gain; debt capacity expanded

Jul 27, 2026, 4:25 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Stronger near-term FFO growth and expanded debt capacity raise the likelihood of dividend support and potential multiple expansion if tenant risk remains manageable; near-term catalysts include the Miller Medical Plaza progress and a higher borrowing capacity enabling capital deployment.

AI summary

What happened, with direct paths to the underlying reporting

UHT posted Q2 2026 net income of $5.9M ($0.43 per diluted share), up from $4.5M in the year-ago quarter. Adjusted net income was $5.2M after a $0.724M land-sale gain, with FFO of $12.5M. The credit facility was expanded to $475M (with $109.4M available) and Miller Medical Plaza development with UHS advances, boosting near-term cash-flow visibility despite ongoing Medicaid funding and rate-constrained risk in healthcare tenants.

Q2 2026 net income $5.9M; diluted EPS $0.43, up from $4.5M/$0.32 in 2025.
Adjusted net income $5.2M; land sale gain $0.724M; FFO $12.5M.
Credit facility expanded to $475M; $109.4M available; borrowings $365.6M as of 6/30/2026.
Miller Medical Plaza MOB: 80k sq ft; cost ~$34M; 75% leased to UHS; completion 12/2026.
Q2 dividend $0.75 per share; June 30, 2026 payment.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.